Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients
Advances in DNA sequencing have made genetic testing fast and affordable, but limitations of testing processes are impeding realisation of patient benefits. Ovarian cancer exemplifies the potential value of genetic testing and the shortcomings of current pathways to access testing. Approximately 15%...
मुख्य लेखकों: | George, A, Riddell, D, Seal, S, Talukdar, S, Mahamdallie, S, Ruark, E, Cloke, V, Slade, I, Kemp, Z, Gore, M, Strydom, A, Banerjee, S, Hanson, H, Rahman, N |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Nature Research
2016
|
समान संसाधन
-
The ICR639 CPG NGS validation series: A resource to assess analytical sensitivity of cancer predisposition gene testing [version 1; referees: 2 approved]
द्वारा: Shazia Mahamdallie, और अन्य
प्रकाशित: (2018-06-01) -
Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
द्वारा: Fowler, A, और अन्य
प्रकाशित: (2016) -
CoverView: a sequence quality evaluation tool for next generation sequencing data [version 1; referees: 2 approved]
द्वारा: Márton Münz, और अन्य
प्रकाशित: (2018-04-01) -
The Quality Sequencing Minimum (QSM): providing comprehensive, consistent, transparent next generation sequencing data quality assurance [version 1; referees: 2 approved, 1 approved with reservations]
द्वारा: Shazia Mahamdallie, और अन्य
प्रकाशित: (2018-04-01) -
Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN [version 1; referees: 2 approved]
द्वारा: Anna Fowler, और अन्य
प्रकाशित: (2016-11-01)